BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29072773)

  • 1. Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma.
    Mokdad AA; Murphy CC; Pruitt SL; Mansour JC; Marrero JA; Singal AG; Yopp AC
    Cancer; 2018 Feb; 124(4):743-751. PubMed ID: 29072773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma.
    Hester CA; Karbhari N; Rich NE; Augustine M; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Singal AG; Yopp AC
    Cancer; 2019 Oct; 125(19):3428-3436. PubMed ID: 31299089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-Hospital Outcomes of Percutaneous Coronary Intervention in America's Safety Net: Insights From the NCDR Cath-PCI Registry.
    Acharya T; Salisbury AC; Spertus JA; Kennedy KF; Bhullar A; Reddy HKK; Joshi BK; Ambrose JA
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1475-1485. PubMed ID: 28797422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitals.
    Vitiello GA; Wang A; Lee RM; Russell MC; Yopp A; Ryon EL; Goel N; Luu S; Hsu C; Silberfein E; Correa-Gallego C; Berman RS; Lee AY
    J Surg Oncol; 2021 Mar; 123(4):963-969. PubMed ID: 33497478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
    Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
    Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
    Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
    J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.
    Stewart SL; Kwong SL; Bowlus CL; Nguyen TT; Maxwell AE; Bastani R; Chak EW; Chen MS
    World J Gastroenterol; 2016 Oct; 22(38):8584-8595. PubMed ID: 27784971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative.
    Lee RM; Gamboa AC; Turgeon MK; Yopp A; Ryon EL; Kronenfeld JP; Goel N; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Maithel SK; Russell MC
    Surg Oncol; 2020 Dec; 35():120-125. PubMed ID: 32871546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry.
    Wong RJ; Devaki P; Nguyen L; Cheung R; Nguyen MH
    Liver Transpl; 2014 May; 20(5):528-35. PubMed ID: 24415542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis.
    Wagle NS; Park S; Washburn D; Ohsfeldt R; Kum HC; Singal AG
    Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):463-470. PubMed ID: 38252039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
    Jones PD; Diaz C; Wang D; Gonzalez-Diaz J; Martin P; Kobetz E
    Dig Dis Sci; 2018 Feb; 63(2):515-528. PubMed ID: 29275448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in hepatocellular carcinoma survival among Californians of Asian ancestry, 1988 to 2007.
    Kwong SL; Stewart SL; Aoki CA; Chen MS
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2747-57. PubMed ID: 20823106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
    Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
    J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007.
    Robbins AS; Cox DD; Johnson LB; Ward EM
    Cancer; 2011 Oct; 117(19):4531-9. PubMed ID: 21448933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma.
    Li J; Hansen BE; Peppelenbosch MP; De Man RA; Pan Q; Sprengers D
    Oncotarget; 2017 Feb; 8(9):15193-15204. PubMed ID: 28122352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival inequity in vulnerable populations with early-stage hepatocellular carcinoma: a United States safety-net collaborative analysis.
    Kronenfeld JP; Ryon EL; Goldberg D; Lee RM; Yopp A; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Russell MC; Merchant NB; Goel N
    HPB (Oxford); 2021 Jun; 23(6):868-876. PubMed ID: 33487553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Risk-Standardized Readmission Rates of Surgical Patients at Safety-Net and Non-Safety-Net Hospitals Using Agency for Healthcare Research and Quality and American Hospital Association Data.
    Talutis SD; Chen Q; Wang N; Rosen AK
    JAMA Surg; 2019 May; 154(5):391-400. PubMed ID: 30649141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.